{"url_path":"/sec/veru/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/863894/0001437749-26-016557-index.html","accession_number":"0001437749-26-016557","cik":"0000863894","ticker":"VERU","issuer_name":"VERU INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/863894/0001437749-26-016557-index.html","primary_entity_key":"0000863894","primary_entity_name":"VERU INC."},"word_count":951,"has_tables":true,"body_markdown":"Item 6. Exhibits\n\n \n\nExhibit\n\nNumber\n\nDescription\n\n2.1\n\n[Asset Purchase Agreement, dated as of April 19, 2023, between the Company and Blue Water Vaccines Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 1-13602) filed with the SEC on April 20, 2023).](http://www.sec.gov/Archives/edgar/data/863894/000119312523107340/d473204dex101.htm)\n\n \n \n\n2.2\n[Amendment to Asset Purchase Agreement, dated as of September 29, 2023, between the Company and Onconetix, Inc. (formerly known as Blue Water Vaccines Inc.) (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 1-13602) filed with the SEC on October 2, 2023).](http://www.sec.gov/Archives/edgar/data/863894/000119312523249207/d536406dex101.htm)\n\n \n \n\n2.3\n[Stock and Asset Purchase Agreement, dated as of December 30, 2024, among Veru Inc., The Female Health Company Limited and Clear Future, Inc. (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 1-13602) filed with the SEC on January 3, 2025).](http://www.sec.gov/Archives/edgar/data/863894/000143774925000208/ex_761253.htm)\n\n \n \n\n3.1\n\n[Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Form SB-2 Registration Statement (File No. 333-89273) filed with the SEC on October 19, 1999).](http://www.sec.gov/Archives/edgar/data/863894/000095012499005508/0000950124-99-005508.txt)\n\n \n \n\n3.2\n\n[Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company increasing the number of authorized shares of common stock to 27,000,000 shares (incorporated by reference to Exhibit 3.2 to the Company's Form SB-2 Registration Statement (File No. 333-46314) filed with the SEC on September 21, 2000).](http://www.sec.gov/Archives/edgar/data/863894/000104216700000058/0001042167-00-000058-0002.txt)\n\n \n \n\n3.3\n\n[Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company increasing the number of authorized shares of common stock to 35,500,000 shares (incorporated by reference to Exhibit 3.3 to the Company's Form SB-2 Registration Statement (File No. 333-99285) filed with the SEC on September 6, 2002).](http://www.sec.gov/Archives/edgar/data/863894/000104216702000129/doc2.txt)\n\n \n \n\n3.4\n\n[Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company increasing the number of authorized shares of common stock to 38,500,000 shares (incorporated by reference to Exhibit 3.4 to the Company's Form 10-QSB (File No. 1-13602) filed with the SEC on May 15, 2003).](http://www.sec.gov/Archives/edgar/data/863894/000104216703000040/doc3.txt)\n\n \n \n\n3.5\n\n[Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company designating the terms and preferences for the Class A Preferred Stock – Series 3 (incorporated by reference to Exhibit 3.5 to the Company's Form 10-QSB (File No. 1-13602) filed with the SEC on May 17, 2004).](http://www.sec.gov/Archives/edgar/data/863894/000104216704000171/fhcmay04exhibit3-5to10qsb.htm)\n\n \n \n\n3.6\n\n[Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company designating the terms and preferences for the Class A Preferred Stock – Series 4 (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K (File No. 1-13602) filed with the SEC on November 2, 2016).](http://www.sec.gov/Archives/edgar/data/863894/000119312516756415/d285700dex31.htm)\n\n \n \n\n3.7\n\n[Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company changing the corporate name to Veru Inc. and increasing the number of authorized shares of common stock to 77,000,000 shares (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K (File No. 1-13602) filed with the SEC on August 1, 2017).](http://www.sec.gov/Archives/edgar/data/863894/000119312517243783/d428988dex31.htm)\n\n \n \n\n3.8\n\n[Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company increasing the number of authorized shares of common stock to 154,000,000 shares (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K (File No. 1-13602) filed with the SEC on March 29, 2019).](http://www.sec.gov/Archives/edgar/data/863894/000119312519092705/d721690dex31.htm)\n\n \n \n\n3.9\n\n[Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company increasing the number of authorized shares of common stock to 308,000,000 shares (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K (File No. 1-13602) filed with the SEC on July 28, 2023).](http://www.sec.gov/Archives/edgar/data/863894/000119312523197705/d515262dex31.htm)\n\n \n \n\n3.10\n[Articles of Amendment to the Amended and Restated Articles of Incorporation of the Company effecting the Reverse Stock Split (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K (File No. 1-13602) filed with the SEC on August 12, 2025).](http://www.sec.gov/Archives/edgar/data/863894/000143774925026037/ex_849266.htm)\n\n \n \n\n40\n\n[Table of Contents](#toc)\n\n \n\n3.11\n\n[Amended and Restated By-Laws (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K (File No. 1-13602) filed with the SEC on May 4, 2018).](http://www.sec.gov/Archives/edgar/data/863894/000119312518152767/d472996dex31.htm)\n\n \n \n\n4.1\n\nAmended and Restated Articles of Incorporation, as amended (same as Exhibits [3.1](http://www.sec.gov/Archives/edgar/data/863894/000095012499005508/0000950124-99-005508.txt), [3.2](http://www.sec.gov/Archives/edgar/data/863894/000104216700000058/0001042167-00-000058-0002.txt), [3.3](http://www.sec.gov/Archives/edgar/data/863894/000104216702000129/doc2.txt), [3.4](http://www.sec.gov/Archives/edgar/data/863894/000104216703000040/doc3.txt), [3.5](http://www.sec.gov/Archives/edgar/data/863894/000104216704000171/fhcmay04exhibit3-5to10qsb.htm), [3.6](http://www.sec.gov/Archives/edgar/data/863894/000119312516756415/d285700dex31.htm), [3.7](http://www.sec.gov/Archives/edgar/data/863894/000119312517243783/d428988dex31.htm), [3.8](http://www.sec.gov/Archives/edgar/data/863894/000119312519092705/d721690dex31.htm), [3.9](http://www.sec.gov/Archives/edgar/data/863894/000119312523197705/d515262dex31.htm), and [3.10](http://www.sec.gov/Archives/edgar/data/863894/000143774925026037/ex_849266.htm)).\n\n \n \n\n4.2\n\n[Articles II, VII and XI of the Amended and Restated By-Laws (included in Exhibit 3.11).](http://www.sec.gov/Archives/edgar/data/863894/000119312518152767/d472996dex31.htm)\n\n \n \n\n31.1\n\n[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.  *](ex_923999.htm)\n\n \n \n\n31.2\n\n[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.  *](ex_924000.htm)\n\n \n \n\n32.1\n\n[Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002).  *, **](ex_924001.htm)\n\n \n \n\n101\n\nThe following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in iXBRL (Inline Extensible Business Reporting Language): (1) the Unaudited Condensed Consolidated Balance Sheets, (2) the Unaudited Condensed Consolidated Statements of Operations, (3) the Unaudited Condensed Consolidated Statements of Stockholders’ Equity, (4) the Unaudited Condensed Consolidated Statements of Cash Flows and (5) the Notes to the Unaudited Condensed Consolidated Financial Statements.\n\n \n \n\n104\n\nCover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).\n\n \n \n\n*\n\nFiled herewith\n\n**\n\nThis certification is not \"filed\" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.\n\n \n\n41\n\n[Table of Contents](#toc)\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\n**VERU INC.**\n\n \n\n \n\nDATE: May 13, 2026\n\n \n\n/s/ Mitchell S. Steiner\n\nMitchell S. Steiner\n\nChairman, Chief Executive Officer and President\n\n \n\n \n\nDATE: May 13, 2026\n\n \n\n/s/ Michele Greco\n\nMichele Greco\n\nChief Financial Officer and Chief Administrative Officer\n\n \n\n42"}